Sinha M., Pietropaolo A., Quiroz Madarriaga Y., de Knecht E.L., Bujons Tur A., Griffin S., Somani B.K.. Outcomes of ureteroscopy for management of stone disease in early and late childhood over a 15-year period. Therapeutic Advances in Urology. 2022; 14DOI:10.1177/17562872221141775. PMID:36568063. IF:2.000(Q3/7D).

Herrero M., Ciruela P., Mendoza S., Mendioroz J., Jané M., Carmona Parcerisa G., Martinez Mateo A.I., Pequeño Saco S., Leon Garcia A.R., Domenech E., Pericas Escalé C., Barrabeig Fabregat I., Rovira Faixa A., Carol Torrades M., Guadalupe Fernandez V., Bes Montalat N., Follia Alsina M.N., Ferras Prats J., Minguell Verges S., Ferrús Serra G., Godoy Garcia P., Alseda Graells M., Parron Bernabe I., Cirera Viladot A., Rius Gibert C., García de Olalla Rizo P., Pérez Albarracín G., Sala Farre M.-R., Clotet Romero L., Herrero Garcia M., Ciruela Navas P., Mallafré-Larrosa M., Mendoza Funes S., Patsi-Bosch G., Martínez-Solanas È., Mendioroz Peña J., Jané Checa M.. SARS-CoV-2 Catalonia contact tracing program: evaluation of key performance indicators. BMC PUBLIC HEALTH. 2022; 22(1)DOI:10.1186/s12889-022-13695-8. PMID:35858841. IF:4.500(Q2/4D).

Mostaza J.M., Suárez-Fernández C., Cosín-Sales J., Gómez-Huelgas R., Brotons C., Araujo F.P., Borrayo G., Ruiz E., Pérez P., Espinosa J., Sobrino J., Posé A., Arroyo Díaz J.A., García Vallejo O., Cubo Romano M.P., Jansen Chaparro S., Cabezón Mariscal J., Rico Corral M.A., Abellán Alemán J., Orozco Beltrán D., Escobar Jimenez L., Valdivieso Felices P., Pedro-Botet Montoya J.C., Masana Marín L., Guijarro C., Díaz Rodríguez Á., Díaz Díaz J.L., De la Peña Fernández A., Coloma Bazán E., Cuenca Acevedo R., Suárez Fernández C., Civeira F., Castellano Vázquez J.M., Mostaza Prieto J.M., Suárez Tembra M., Alfonso Megido J., Castiella Herrero J., Tamarit J.J., Martínez-Hervás Alonso M.Á., Carrasco Franco F.J., Álvarez Sala L., Calderón Sandubete E., Rovira Daudi E., Bonilla Rovira F., Murcia Zaragoza J.M., Cuixart Costa L., Bianchi Llave J.L., Álvarez Sánchez C., Marqués Da Silva P., Cunha V., Santos C., Araujo F., Moura J., Rosas Peralta M.. Safety and efficacy of a cardiovascular polypill in people at high and very high risk without a previous cardiovascular event: the international VULCANO randomised clinical trial. BMC Cardiovascular Disorders. 2022; 22(1)DOI:10.1186/s12872-022-03013-w. PMID:36550424. IF:2.100(Q3/8D).

Salgueiro, C, Urrutia, G, Cabanas-Valdes, R. Telerehabilitation for balance rehabilitation in the subacute stage of stroke: A pilot controlled trial. NEUROREHABILITATION. 2022; 51(1)DOI:10.3233/NRE-210332. PMID:35311721. IF:2.000(Q2/5D).

Torres, ML, Diaz, DP, Oliver-Parra, A, Millet, JP, Cosialls, D, Guillaumes, M, Rius, C, Vasquez-Vera, H. Inequities in the incidence and mortality due to COVID-19 in nursing homes in Barcelona by characteristics of the nursing homes. PLoS One. 2022; 17(6)DOI:10.1371/journal.pone.0269639. PMID:35696404. IF:3.700(Q2/4D).

Chastre J., François B., Bourgeois M., Komnos A., Ferrer R., Rahav G., De Schryver N., Lepape A., Koksal I., Luyt C.-E., Sánchez-García M., Torres A., Eggimann P., Koulenti D., Holland T.L., Ali O., Shoemaker K., Ren P., Sauser J., Ruzin A., Tabor D.E., Akhgar A., Wu Y., Jiang Y., DiGiandomenico A., Colbert S., Vandamme D., Coenjaerts F., Malhotra-Kumar S., Timbermont L., Oliver A., Barraud O., Bellamy T., Bonten M., Goossens H., Reisner C., Esser M.T., Jafri H.S., Joannidis M., Klimscha W., De Waele E., Devriendt J., Huberlant V., Depuydt P., Van Boxstael S., Peric M., Kopic J., Hanauer M., Hruby T., Sramek V., Svoboda P., Vymazal T., Novacek M., Annane D., Mira J.-P., Souweine B., Dequin P.-F., Meziani F., Stephan F., Nseir S., Gibot S., Schwebel C., Plantefeve G., Diehl J.-L., Richard C., Lamer C., Klouche K., Jaber S., Zakynthinos E., Filntisis G., Zakynthinos S., Koutsoukou A., Saroglou G., Nikolaou C., Vlachogianni G., Pnevmatikos I., Mandragos K., Kremer I., Rozgonyi Z.D., Marjanek Z., Martin-Loeches I., Singer P., Van Heerden V., Carmeli Y., Povoa P., Seoane A.A., Moura P., Gonzalez F., Ramirez P., Marti A.T., Roca R.F., Oteiza L., Escudero D., Piacentini E., Vera P., Tamayo L., Gallego M.A.G., Canas B.S., Figueira I., Leon R., Korten V., Akova M., Wyncoll D., Whitehouse T., Hopkins P., Sim M., Golan Y., Zervos M., Vazquez J., Cherabuddi K., Smulian G., Rouphael N., Welker J., Sims M., Van Duin D., McCarthy T., Polk C.. Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial. CRITICAL CARE. 2022; 26(1)DOI:10.1186/s13054-022-04204-9. PMID:36380312. IF:15.100(Q1/2D).